ANGELO GORDON & CO., L.P. - PROTALIX BIOTHERAPEUTICS INC ownership

Quarter-by-quarter ownership
ANGELO GORDON & CO., L.P. ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2021$1,412,000
+1.1%
1,397,0000.0%0.08%
+11.3%
Q2 2021$1,397,000
+2.9%
1,397,0000.0%0.07%
-39.8%
Q1 2021$1,357,000
+2.7%
1,397,0000.0%0.12%0.0%
Q4 2020$1,321,000
+3.5%
1,397,0000.0%0.12%
-17.5%
Q3 2020$1,276,000
-51.1%
1,397,000
-51.5%
0.14%
-59.9%
Q2 2020$2,610,000
+1.8%
2,879,0000.0%0.36%
+86.9%
Q1 2020$2,563,000
+2.4%
2,879,0000.0%0.19%
-50.5%
Q4 2019$2,502,000
+9.9%
2,879,0000.0%0.39%
+33.1%
Q3 2019$2,276,000
-17.3%
2,879,0000.0%0.29%
-7.6%
Q2 2019$2,752,000
+0.3%
2,879,0000.0%0.31%
+22.2%
Q1 2019$2,743,000
+0.2%
2,879,0000.0%0.26%
+49.4%
Q4 2018$2,737,000
+0.1%
2,879,0000.0%0.17%
-20.0%
Q3 2018$2,735,000
+10.2%
2,879,0000.0%0.22%
+35.2%
Q2 2018$2,482,000
-9.9%
2,879,0000.0%0.16%
+9.7%
Q1 2018$2,756,000
-50.4%
2,879,000
-50.0%
0.14%
-5.8%
Q4 2017$5,552,000
+243.8%
5,758,000
+197.1%
0.15%
+105.3%
Q3 2017$1,615,000
-26.0%
1,938,0000.0%0.08%
-29.9%
Q2 2017$2,183,000
-29.5%
1,938,0000.0%0.11%
-43.4%
Q1 2017$3,096,000
+84.4%
1,938,0000.0%0.19%
+53.7%
Q4 2016$1,679,0001,938,0000.12%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
HIGHBRIDGE CAPITAL MANAGEMENT LLC 31,014,000$29,401,0001.13%
UBS OCONNOR LLC 8,000,000$7,440,000,0000.15%
WHITEBOX ADVISORS LLC 5,000,000$4,727,0000.15%
ANGELO GORDON & CO., L.P. 1,397,000$1,321,0000.12%
INGALLS & SNYDER LLC 500,000$474,0000.02%
CITIGROUP INC 7,832,000$7,404,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders